A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss.

Yes, the same company known for DNA testing and ancestry records is now helping connect people to GLP-1 prescriptions and other medications via Lemonaid Health, its telehealth platform designed to ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has conclu ...

Like so many issues in life, taking a short walk or spin on your bike, can provide some relief when it comes to food noise.

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

RAs are transforming obesity treatment, demonstrating substantial weight loss and metabolic improvements with lifestyle ...

While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic ...

A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.

When Trova Wine and Market in Dallas shut its doors last month after nearly five years in business, owner Michelle Bonds ...